JPMORGAN CHASE & CO - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 4 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q4 2018$1,571,000
-37.9%
55,000
-3.5%
0.00%
Q3 2018$2,528,000
-14.0%
57,000
+14.0%
0.00%
-100.0%
Q2 2018$2,938,00050,0000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 444,300$68,027,0000.12%
Marathon Trading Investment Management LLC 3,400$521,0000.03%
SIMPLEX TRADING, LLC 935$14,315,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders